Title : A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers.

Pub. Date : 2017 Oct

PMID : 28833669






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Releasing beta-lapachone first from the CARNs selectively increases the ROS level in cancer cells via NAD(P)H:quinone oxidoreductase-1 (NQO1) catalysis, which induces the cascade amplification release of DOX and overcomes multidrug resistance (MDR) in cancer cells, producing a remarkably improved therapeutic efficacy against MDR tumors with minimal side effects. Reactive Oxygen Species NAD(P)H quinone dehydrogenase 1 Homo sapiens
2 Releasing beta-lapachone first from the CARNs selectively increases the ROS level in cancer cells via NAD(P)H:quinone oxidoreductase-1 (NQO1) catalysis, which induces the cascade amplification release of DOX and overcomes multidrug resistance (MDR) in cancer cells, producing a remarkably improved therapeutic efficacy against MDR tumors with minimal side effects. Reactive Oxygen Species NAD(P)H quinone dehydrogenase 1 Homo sapiens